600557 logo

Jiangsu Kanion Pharmaceutical Co.,Ltd. Stock Price

SHSE:600557 Community·CN¥7.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600557 Share Price Performance

CN¥13.99
-0.55 (-3.78%)
CN¥13.99
-0.55 (-3.78%)
Price CN¥13.99

600557 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
2 Rewards

Jiangsu Kanion Pharmaceutical Co.,Ltd. Key Details

CN¥3.1b

Revenue

CN¥978.9m

Cost of Revenue

CN¥2.2b

Gross Profit

CN¥1.9b

Other Expenses

CN¥281.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 23, 2026
0.50
68.76%
8.98%
0.04%
View Full Analysis

About 600557

Founded
1975
Employees
6132
CEO
Yongchun Yang
WebsiteView website
www.kanion.com

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China.

Recent 600557 News & Updates

Recent updates

No updates